arBtrage CAPITALIZING MARKETS checking… Sign in

AnaptysBio, Inc.

ANAB Health Care Biotechnology: Pharmaceutical Preparations
$50.37
▼ -2.5% Today
as of Jun 7, 07:09 ET
Last 30 days -23.81% Apr 28 → Jun 05
$48.82 $54.45 $60.07 $65.70 $71.33 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$50.58
High
$52.28
Low
$50.36
Volume
$513,493
Avg Vol
$796,051
Mkt Cap
$1.7B
P/E (TTM)
Beta
52w High
$72.36
52w Low
$11.40
Div Yield
Shares Out
$29M

Overview

52-week range
$11
$72
64% of range
Avg surprise (last 2)
-236.7%
Avg reaction (last 2)
-2.8%
0% positive
Latest IV / EM
105%
EM ±14.6% · $50 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.84$-1.25$-0.66$-0.07$0.52 Actual $-1.50Actual $-1.41Actual $-1.64Actual $-1.71Actual $-1.14Actual $-1.28Est $-1.30Actual $-1.34Actual $0.52Actual $-1.84Est $-0.32 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-53M$-20M$14M$47M$80M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-1.84 $-0.32 -475.0% -43.8% -3.4% earnings
Tue Sep 30, 2025Sep 2025 $0.52 financials
Mon Jun 30, 2025Jun 2025 $-1.34 financials
Mon May 5, 2025Mar/2025 $-1.28 $-1.30 +1.5% -2.2% earnings
Mon Sep 30, 2024Sep 2024 $-1.14 financials
Sun Jun 30, 2024Jun 2024 $-1.71 financials
Sun Mar 31, 2024Mar 2024 $-1.64 financials
Sat Sep 30, 2023Sep 2023 $-1.41 financials
Fri Jun 30, 2023Jun 2023 $-1.50 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$26M$76M$22M$28M$30M$11M
Cost of revenue
Gross profit
Operating income$-35M$35M$-26M$-28M$-23M$-40M
Net income$-53M$15M$-39M$-39M$-33M$-47M
EPS (diluted)$-1.84$0.52$-1.34$-1.28$-1.14$-1.71

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$248M$238M$110M$44M$99M$123M$192M$72M
Inventory
Total current assets$316M$350M$331M$292M$363M$432M$449M$367M
Total assets$330M$364M$353M$335M$422M$484M$493M$427M
Long-term debt
Total liabilities
Total equity$13M$37M$-29M$-45M$34M$71M$84M$10M

Implied volatility — last 90 days

100%102%105%107%110% Jun 07 — IV 105% · EM ±14.6%

Sector peers